|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.5 EUR | -4.71% |
|
-4.16% | -8.89% |
| Apr. 29 | STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank reiterates its Neutral rating | ZD |
| Apr. 26 | STRATEC BIOMEDICAL SYSTEMS AG : Berenberg reiterates its Neutral rating | ZD |
Stratec SE reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was EUR 50.87 million compared to EUR 60.48 million a year ago. Net income was EUR 0.447 million compared to EUR 1.37 million a year ago.
Basic earnings per share from continuing operations was EUR 0.04 compared to EUR 0.11 a year ago. Diluted earnings per share from continuing operations was EUR 0.04 compared to EUR 0.11 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.89% | 571M | |
| +8.07% | 219B | |
| +7.87% | 184B | |
| +12.75% | 138B | |
| -1.37% | 62.54B | |
| +4.88% | 52.22B | |
| +11.59% | 51.73B | |
| +2.71% | 41.4B | |
| +4.90% | 37.17B | |
| +23.75% | 31.76B |
STRATEC SE 